Page 5 - Rigel Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rigel pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rigel Pharmaceuticals Today - Breaking & Trending Today

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of "Hold" by Brokerages

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of "Hold" by Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

News Ratings For Rigel Pharmaceuticals Daily , Tower Research Capital , Cantor Fitzgerald , Wealth Concepts , Rigel Pharmaceuticals , Rigel Pharmaceuticals Stock Down , Analyst Recommendations For Rigel Pharmaceuticals , Institutional Investors Weigh In On Rigel Pharmaceuticals , Lido Advisors , York Mellon Corp , Rigel Pharmaceuticals Inc , Get Free Report , Wealth Advisors , Research Capital , New York Mellon Corp , Pharmaceuticals Stock Down , Get Free , Rigel Pharmaceuticals Daily ,

Rigel Pharma Names Rojkjaer EVP, Chief Medical Officer

(RTTNews) - Tuesday, Rigel Pharmaceuticals, Inc. (RIGL) appointed Lisa Rojkjaer, as executive vice president and chief medical officer. Rojkjae. ....

Lisa Rojkjaer , Rigel Pharmaceuticals Inc , Rigel Pharmaceuticals , Chief Medical Officer ,

B. Riley Reiterates Neutral Rating for Rigel Pharmaceuticals (NASDAQ:RIGL)

B. Riley reissued their neutral rating on shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $1.25 price objective on the biotechnology company’s stock. B. Riley also issued estimates for Rigel Pharmaceuticals’ Q1 2024 earnings at ($0.01) EPS, Q2 2024 earnings at ($0.04) […] ....

Analyst Recommendations For Rigel Pharmaceuticals , Rigel Pharmaceuticals Stock Performance , Rigel Pharmaceuticals Company Profile , News Ratings For Rigel Pharmaceuticals Daily , Sg Americas Securities , Rigel Pharmaceuticals Inc , Rigel Pharmaceuticals , Tower Research Capital , Wealth Concepts , Free Report , Research Capital , Wealth Advisors , Get Free Report , Rigel Pharmaceuticals Daily ,

Rigel Pharmaceuticals (RIGL) to Release Earnings on Tuesday

Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) will be announcing its earnings results after the market closes on Tuesday, March 5th. Analysts expect the company to announce earnings of ($0.04) per share for the quarter. Rigel Pharmaceuticals Stock Up 5.6 % RIGL stock opened at $1.50 on Wednesday. The business has a 50 day moving […] ....

Rigel Pharmaceuticals , News Ratings For Rigel Pharmaceuticals Daily , Rigel Pharmaceuticals Stock , Institutional Trading Of Rigel Pharmaceuticals , Goldman Sachs Group Inc , Vanguard Group Inc , Rigel Pharmaceuticals Inc , Earnings History For Rigel Pharmaceuticals , Get Free Report , Street Corp , Sigma Advisers , Zentral Genossenschafts Bank Frankfurt , Goldman Sachs Group , Sachs Group , Rigel Pharmaceuticals Daily ,

Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil

Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Samira Sakhia , Biotoscana Farma , Arvind Utchanah , Rigel Pharmaceuticals Inc , Knight Therapeutics Inc , Therapeutics Inc , United Medical Ltda , Latin America , Chief Executive Officer , Knight Therapeutics , Rigel Pharmaceuticals , Latin American , United Medical , Annual Report , Annual Information Form ,